DiaSorin S.p.A. (DSRLF)
OTCMKTS
· Delayed Price · Currency is USD
104.69
0.00 (0.00%)
May 12, 2025, 4:00 PM EDT
DiaSorin Employees
As of December 31, 2024, DiaSorin had 3,308 total employees, including 3,249 full-time and 59 part-time employees. The number of employees increased by 75 or 2.32% compared to the previous year.
Employees
3,308
Change (1Y)
75
Growth (1Y)
2.32%
Revenue / Employee
$398,660
Profits / Employee
$63,982
Market Cap
5.82B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
CytoDyn | 9 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
DiaSorin News
- 11 days ago - DiaSorin: Anticipate A Double-Digit EBITDA Growth Rate - Seeking Alpha
- 2 months ago - DiaSorin S.p.A. (DSRLF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Italy's DiaSorin ex-Covid revenue in line with guidance - Reuters
- 6 months ago - Diagnostics group DiaSorin's nine-month adjusted core profit up 6% - Reuters
- 10 months ago - DiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Diasorin 2023 revenue drops 14%, in line with guidance; shares fall - Reuters
- 1 year ago - DiaSorin S.p.A. (DSRLF) Q3 2023 Earnings Call Transcript - Seeking Alpha